Document Classification

Section Type: RESULTS

Text: Docetaxel thiotepa group (21 cases) and docetaxel combined with capecitabine group (22 cases) were evaluated for their clinical responses, which showed that 2 of the 21 (9. 52 %) from TXT/TSPA group and 6 of the 22 (27. 27 %) from TXT/CAPE group had achieved partial remission ; 11 of the 21 (52. 38 %) from TXT/TSPA group versus 7 of the 22 (31. 82 %) from TXT/CAPE group for stable diseases ; 8 of the 21 (38. 10 %) from TXT/TSPA group versus and 9 of the 22 (40. 91 %) from TXT/CAPE group for progressive diseases, respectively.